Welcome to our dedicated page for Adams Diversified Equity Fund news (Ticker: ADX), a resource for investors and traders seeking the latest updates and insights on Adams Diversified Equity Fund stock.
Adams Diversified Equity Fund, Inc. reports developments for an internally managed closed-end diversified equity fund listed on the NYSE under ADX. News releases commonly cover net asset value and market-price returns, comparisons with the S&P 500 Index and Morningstar U.S. Large Blend category, shareholder reports, and the Fund's largest equity holdings.
Recurring updates also include distribution policy, year-end distributions, sources of distributions, share counts, net assets, and closed-end fund capital actions such as tender offers for common shares.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
The Board of Directors of Adams Diversified Equity Fund (NYSE: ADX) declared a distribution of $0.05 per share from net investment income, payable on June 1, 2023, to shareholders of record by May 18, 2023. This marks the second payment in 2023 toward the Fund's commitment to a 6% minimum annual distribution rate. For the first quarter of 2023, the total return on the Fund's net asset value, with dividends reinvested, was 6.9%, slightly below the S&P 500's 7.5%. However, the 12-month return was -7.7%, matching the S&P 500, while the market price return was worse at -9.7%. The Fund's net assets decreased to approximately $2.24 billion from $2.53 billion a year prior, with shares outstanding increasing. The net asset value per share stands at $18.52, down from $21.49.
Adams Funds, comprising Adams Diversified Equity Fund (NYSE: ADX) and Adams Natural Resources Fund (NYSE: PEO), announced the retirement of CEO Mark E. Stoeckle after a decade of leadership. He served as CEO since February 2013 and will remain on the Boards of Directors. Stoeckle previously enjoyed a 32-year career in financial services, including positions at BNP Paribas and Bear, Stearns & Co. His successor, James P. Haynie, has been appointed as the new CEO effective immediately. Chairman Kenneth J. Dale praised Stoeckle's contributions, particularly during challenging market conditions and the pandemic. Adams Funds, established in 1929, focuses on achieving a 6% annual distribution rate to provide reliable income to its investors.
Celularity Inc. has entered into an exclusive distribution agreement with AD Ports Logistics to distribute Halal-Certified regenerative medicines and wellness products across the Middle East, including UAE, Qatar, Bahrain, Oman, Kuwait, and Egypt. This partnership follows a prior agreement for Saudi Arabia and aims to enhance access to innovative healthcare solutions in the region. Celularity's commercial biomaterial products include various types derived from human placental tissue. The regenerative medicine market is expected to grow significantly, reaching $37.10 billion by 2030, highlighting the importance of this distribution deal for both companies.